Research on human cells reprogramming in Andalusia (Spain): Quo vadis Europe?
García San José, Daniel
Revista de derecho y genoma humano = Law and the human genome review / Cátedra de Derecho y Genoma Humano/Fundación BBV-Diputación Foral de Bizkaia 2010 Jan-Jun(32): 25-45
Andalusia has a special situation within Spain, among the group of countries that lead biomedical research on embryonic cell reprogramming at a global level, research which seems to have overcome the moral and ethical controversy surrounding other research techniques involving the creation-destruction of human embryos. Nevertheless, as there is no common European conception of human life, some ethical problems could emerge in the near future when it comes to patenting the results of these cell-reprogramming techniques at a European level.
Showing items related by title, author, creator and subject.
Idiakez, Itziar Alkorta (2008-07)
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 Testing in Gastric Carcinoma Gómez-Martín, Carlos; Concha, Angel; Corominas, José María; García-Caballero, Tomás; García-García, Elena; Iglesias, Mar; López, José Antonio; Ramón y Cajal, Santiago; Rojo, Federico; Palacios, José; Vera-Sempere, Francisco; Aranda, Enrique; Colomer, Ramon; García-Alfonso, Pilar; Garrido, Pilar; Rivera, Fernando; López-Ríos, Fernando (Spanish Society of Medical Oncology; Spanish Society of Pathology, 2011-09)The identification of HER2 alterations in advanced gastric carcinomas is of critical importance in daily clinical practice as such neoplasms require specific treatment with trastuzumab. For these reasons, pathologists and ...
Cowan, Chad A.; Atienza, Jocelyn; Melton, Douglas A.; Eggan, Kevin (2005-08-26)